This promotional session is organised and funded by Daiichi Sankyo UK and is for healthcare professionals in the UK only. Daiichi Sankyo UK products will be discussed at the meeting, where prescribing information and adverse event reporting will be available. 

Daiichi Sankyo UK has had no further input into the content for the rest of the conference. 

This educational session will provide attendees with an overview of clinical management for raised cholesterol, including cardiovascular disease risk assessment, treatment guidelines, and discuss available lipid-lowering therapies to support better patient care. 

The session will also explore the potential system-wide value of effective lipid control, considering clinical outcomes, economic impact, and patient perspectives.

UK/BEM/04/25/0022

April 2025